[LDN_Cancer] reports that the late Dr. Bernard Bihari treated approximately 450
patients with some form of cancer, with a 60% success rate, almost all of who had failed to
respond to standard treatments.
In particular, 18 patients with non-small cell cancer of the lung and 1 patient with small
cell cancer of the lung appeared to be in remission.
In one case, progression of the lung tumor mass and metastatic mass was halted for 40 months
of follow-up (as shown by CAT scans every 6 months).
In another case, after 5.5 months of LDN treatment of non-small cell lung cancer with a
metastatic lesion to the neck, 80% shrinkage of the metastatic lesion and 20% shrinkage of
the primary masses in both lungs was observed.
The patient remained stable for the next 3 and a half years.
See also [Miskoff2018 🕮 ]
Dr. Weyrich has been trained to use Low Dose Naltrexone (LDN).
However, Dr. Weyrich has not treated any cases of lung cancer with LDN.
Please see What is Low Dose Naltrexone?
for more information.